507 related articles for article (PubMed ID: 27246042)
21. Retinoid acid induced 16 deficiency aggravates colitis and colitis-associated tumorigenesis in mice.
Xu YL; Ding CL; Qian CL; Qi ZT; Wang W
Cell Death Dis; 2019 Dec; 10(12):958. PubMed ID: 31862898
[TBL] [Abstract][Full Text] [Related]
22. Aqueous extracts of Ocimum gratissimum mitigate colitis and protect against AOM/DSS-induced colorectal cancer in mice.
Liu JY; Tsai FL; Chuang YL; Ye JC
Carcinogenesis; 2023 Dec; 44(12):837-846. PubMed ID: 37864831
[TBL] [Abstract][Full Text] [Related]
23. Tumor Necrosis Factor Ligand-Related Molecule 1A Regulates the Occurrence of Colitis-Associated Colorectal Cancer.
Niu W; Wu Z; Wang J; Zhang H; Jia W; Yang M; Luo Y; Zhang X
Dig Dis Sci; 2018 Sep; 63(9):2341-2350. PubMed ID: 29796912
[TBL] [Abstract][Full Text] [Related]
24. Effect of Estradiol in an Azoxymethane/Dextran Sulfate Sodium-Treated Mouse Model of Colorectal Cancer: Implication for Sex Difference in Colorectal Cancer Development.
Son HJ; Sohn SH; Kim N; Lee HN; Lee SM; Nam RH; Park JH; Song CH; Shin E; Na HY; Kim JS; Lee DH; Surh YJ
Cancer Res Treat; 2019 Apr; 51(2):632-648. PubMed ID: 30064198
[TBL] [Abstract][Full Text] [Related]
25. Prevention of Colitis and Colitis-Associated Colorectal Cancer by a Novel Polypharmacological Histone Deacetylase Inhibitor.
Wei TT; Lin YT; Tseng RY; Shun CT; Lin YC; Wu MS; Fang JM; Chen CC
Clin Cancer Res; 2016 Aug; 22(16):4158-69. PubMed ID: 27528734
[TBL] [Abstract][Full Text] [Related]
26. Peptide TNIIIA2 Derived from Tenascin-C Contributes to Malignant Progression in Colitis-Associated Colorectal Cancer via β1-Integrin Activation in Fibroblasts.
Fujita M; Ito-Fujita Y; Iyoda T; Sasada M; Okada Y; Ishibashi K; Osawa T; Kodama H; Fukai F; Suzuki H
Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31195598
[TBL] [Abstract][Full Text] [Related]
27. Differences in colonic crypt morphology of spontaneous and colitis-associated murine models via second harmonic generation imaging to quantify colon cancer development.
Prieto SP; Reed CL; James HM; Quinn KP; Muldoon TJ
BMC Cancer; 2019 May; 19(1):428. PubMed ID: 31072353
[TBL] [Abstract][Full Text] [Related]
28. Establishment of a Novel Colitis-Associated Cancer Mouse Model Showing Flat Invasive Neoplasia.
Uragami T; Ando Y; Aoi M; Fukui T; Matsumoto Y; Horitani S; Tomiyama T; Okazaki K; Tsuneyama K; Tanaka H; Naganuma M
Dig Dis Sci; 2023 May; 68(5):1885-1893. PubMed ID: 36504013
[TBL] [Abstract][Full Text] [Related]
29. Activation of the mTORC1 and STAT3 pathways promotes the malignant transformation of colitis in mice.
He Z; He X; Chen Z; Ke J; He X; Yuan R; Cai Z; Chen X; Wu X; Lan P
Oncol Rep; 2014 Nov; 32(5):1873-80. PubMed ID: 25174408
[TBL] [Abstract][Full Text] [Related]
30. Upregulation of PD-1 follows tumour development in the AOM/DSS model of inflammation-induced colorectal cancer in mice.
Yassin M; Sadowska Z; Djurhuus D; Nielsen B; Tougaard P; Olsen J; Pedersen AE
Immunology; 2019 Sep; 158(1):35-46. PubMed ID: 31429085
[TBL] [Abstract][Full Text] [Related]
31. Establishing the colitis-associated cancer progression mouse models.
Zheng H; Lu Z; Wang R; Chen N; Zheng P
Int J Immunopathol Pharmacol; 2016 Dec; 29(4):759-763. PubMed ID: 27694612
[TBL] [Abstract][Full Text] [Related]
32. Dietary cocoa protects against colitis-associated cancer by activating the Nrf2/Keap1 pathway.
Pandurangan AK; Saadatdoust Z; Esa NM; Hamzah H; Ismail A
Biofactors; 2015; 41(1):1-14. PubMed ID: 25545372
[TBL] [Abstract][Full Text] [Related]
33. MyD88 adaptor-like (Mal) regulates intestinal homeostasis and colitis-associated colorectal cancer in mice.
Aviello G; Corr SC; Johnston DG; O'Neill LA; Fallon PG
Am J Physiol Gastrointest Liver Physiol; 2014 May; 306(9):G769-78. PubMed ID: 24603458
[TBL] [Abstract][Full Text] [Related]
34. [Inflammation promotes the development of colitis-associated colorectal cancer].
He Z; Ke J; He X; Lian L; Sun L; Chen Z; Wu X; Lan P
Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Jul; 17(7):706-10. PubMed ID: 25070454
[TBL] [Abstract][Full Text] [Related]
35. Short-chain fatty acids administration is protective in colitis-associated colorectal cancer development.
Tian Y; Xu Q; Sun L; Ye Y; Ji G
J Nutr Biochem; 2018 Jul; 57():103-109. PubMed ID: 29694938
[TBL] [Abstract][Full Text] [Related]
36. Dose-dependent promoting effect of dextran sodium sulfate on mouse colon carcinogenesis initiated with azoxymethane.
Suzuki R; Kohno H; Sugie S; Tanaka T
Histol Histopathol; 2005 Apr; 20(2):483-92. PubMed ID: 15736053
[TBL] [Abstract][Full Text] [Related]
37. Chemotherapy-induced mucositis development in a murine model of colitis-associated colorectal cancer.
Chartier LC; Howarth GS; Mashtoub S
Scand J Gastroenterol; 2020 Jan; 55(1):47-54. PubMed ID: 31825688
[No Abstract] [Full Text] [Related]
38. Apolipoprotein A-I inhibits experimental colitis and colitis-propelled carcinogenesis.
Gkouskou KK; Ioannou M; Pavlopoulos GA; Georgila K; Siganou A; Nikolaidis G; Kanellis DC; Moore S; Papadakis KA; Kardassis D; Iliopoulos I; McDyer FA; Drakos E; Eliopoulos AG
Oncogene; 2016 May; 35(19):2496-505. PubMed ID: 26279300
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA 301A Promotes Intestinal Inflammation and Colitis-Associated Cancer Development by Inhibiting BTG1.
He C; Yu T; Shi Y; Ma C; Yang W; Fang L; Sun M; Wu W; Xiao F; Guo F; Chen M; Yang H; Qian J; Cong Y; Liu Z
Gastroenterology; 2017 May; 152(6):1434-1448.e15. PubMed ID: 28193514
[TBL] [Abstract][Full Text] [Related]
40. Identification of novel Nrf2 target genes as prognostic biomarkers in colitis-associated colorectal cancer in Nrf2-deficient mice.
Hammad A; Zheng ZH; Gao Y; Namani A; Shi HF; Tang X
Life Sci; 2019 Dec; 238():116968. PubMed ID: 31628914
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
